Expanding public education, increasing access and quality of care, supporting family caregivers and increasing training for ...

Though Lilly has been in the spotlight for the success of its GLP-1 drugs, the pharma giant has also been investing in a corporate brand campaign to boost its overall reputation.

TV presenter Ruth Langsford has spoken out on her ongoing 'fear' of getting a life-changing illness after watching both her ...

NICE has said the Alzheimer's disease drug is too expensive to be available on the NHS, but researchers are now hoping to ...

Donanemab and another new drug for Alzheimer’s called Lecanemab have been billed as a huge step forward in research ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

If I were a statistician tucked away in an NHS backroom, I might well curse the day the health service was founded. There, on ...

The drug is the second Alzheimer’s medicine to receive a lukewarm reception from the UK government in recent months.View on ...

Ruth Langsford said she doesn't fear ageing following her split from Eamonn Holmes and hopes to remain active in the years to ...

The Dementia Trials Accelerator (DTA) – which will be spearheaded by the UK Dementia Research Institute (UK DRI) and Health ...

The UK’s National Institute of Health and Care Excellence (NICE) said the drug provided only a small benefit to patients.

There have been many promising leads for an Alzheimer's vaccine but new treatments have been slow to merge. Researchers at ...